Gupta, S., Cheung, L., Pokkali, S., Winglee, K., Guo, H., Murphy, J. R., & Bishai, W. R. (2017). Suppressor Cell–Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis. J Infect Dis.
Citação norma ChicagoGupta, Shashank, Laurene Cheung, Supriya Pokkali, Kathryn Winglee, Haidan Guo, John R. Murphy, and William R. Bishai. "Suppressor Cell–Depleting Immunotherapy With Denileukin Diftitox Is an Effective Host-Directed Therapy for Tuberculosis." J Infect Dis 2017.
Citação norma MLAGupta, Shashank, et al. "Suppressor Cell–Depleting Immunotherapy With Denileukin Diftitox Is an Effective Host-Directed Therapy for Tuberculosis." J Infect Dis 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.